Search results for: 'philippines otc market'

This research service presents an overview and analysis of the clinical trials and research outsourcing market in the Philippines from the time period 2009 to 2015. It goes over government regulations, clinical trial statistics by phase and therapeutic area, and growth of the clinical trials market. Along with this coverage, the research service a...

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in the Philippines.

The Philippines is a part of the Association of Southeast Asian Nations (ASEAN) community and one of the fastest growing healthcare markets in the region. With regard to healthcare, the Philippine Government has been looking at ways to achieve 100% enrolment to PhilHealth by 2020. One of the means is by mandating all Filipinos to enrol to PhilHealt...

06 Feb 2020  |  Asia Pacific  |  Market Research

Philippine Diabetes Devices Market, Forecast to 2023

Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

The study covers the eHealth initiatives across the emerging markets in Asia-Pacific. Government initiatives and incentives that encourage technology adoption in healthcare are key drivers for private sector investment in the Asia-Pacific eHealth industry. However, inadequate infrastructure and regulatory framework development have adversely affect...

The pharmaceutical industry in Ghana and Nigeria is forecast to represent a combined business opportunity of over $3 billion by 2018, propelled by a convergence of changing economic profiles, increased healthcare spending and investment, and increasing incidence of chronic diseases. Market segmentation is done based on products (OTC, generic, and b...

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-counter (OTC) CGM, growing adoption among non-insulin...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...

Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...